{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:45:06Z","timestamp":1793810706151,"version":"4.6.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Antibiotic resistance in\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      is a major threat to global health. Despite its clinical importance, regional data from Saudi Arabia remain limited. This study analyzed the resistance patterns of\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      isolates collected from the King Fahad Specialist Hospital in Al-Qassim between January 2015 and December 2023.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>\n                      A retrospective cross-sectional analysis was conducted on 3,838 confirmed\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      cases. Data were extracted from hospital electronic records and analyzed using R software. Descriptive and inferential statistics were used to examine resistance patterns by specimen type, age, sex, and hospital department.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>High resistance rates were observed to first-line antibiotics, particularly third-generation cephalosporins (59.18%\u201368.69%), amoxicillin-clavulanate (58.38%), and piperacillin-tazobactam (52.81%). Resistance to fluoroquinolones ranged from 53.85% to 56.36%. In contrast, higher susceptibility was observed for aminoglycosides and carbapenems. Resistance was more frequent in ESBL-producing strains, with limited presence of MDR strains. Age and sex were associated with an increased risk of resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      isolates in this study demonstrated significant resistance to commonly prescribed antibiotics. ESBL production substantially contributed to resistance patterns. Although aminoglycosides and carbapenems have shown relative effectiveness, emerging resistance trends underscore the need for continuous monitoring and strict antibiotic stewardship in hospital settings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-14159-9","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T08:46:14Z","timestamp":1785573974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antimicrobial resistance patterns of Klebsiella pneumoniae clinical isolates in the Qassim region, Saudi Arabia: a surveillance study (2015\u20132023)"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1631-6467","authenticated-orcid":false,"given":"Noorah","family":"Al-Sowayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0160-2743","authenticated-orcid":false,"given":"Farah","family":"Al-masoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2992-2307","authenticated-orcid":false,"given":"Manal","family":"Almutari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7182-5345","authenticated-orcid":false,"given":"Malak","family":"Almunife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0247-259X","authenticated-orcid":false,"given":"Tahani","family":"Esmail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"14159_CR1","unstructured":"O\u2019Neill J. Tackling drug-resistant infections globally: final report and recommendations. The Review on Antimicrobial Resistance. 2016 May. https:\/\/apo.org.au\/sites\/default\/files\/resource-files\/2016-05\/apo-nid63983.pdf."},{"key":"14159_CR2","unstructured":"Antimicrobial resistance. Global Report on Surveillance. World Health Organization. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/112642\/9789241564748_eng.pdf?sequence=1. Accessed May 5, 2019."},{"key":"14159_CR3","doi-asserted-by":"publisher","unstructured":"Holt KE, Wertheim H, Zadoks RN et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proceedings of the National Academy of Sciences. 2015;112(27). https:\/\/doi.org\/10.1073\/pnas.1501049112.","DOI":"10.1073\/pnas.1501049112"},{"issue":"3","key":"14159_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1128\/cmr.00096-12","volume":"26","author":"HM -Zowawi","year":"2013","unstructured":"Zowawi HM, Balkhy HH, Walsh TR, Paterson DL. \u03b2-Lactamase Production in Key Gram-Negative Pathogen Isolates from the Arabian Peninsula. Clin Microbiol Rev. 2013;26(3):361\u201380. https:\/\/doi.org\/10.1128\/cmr.00096-12.","journal-title":"Clin Microbiol Rev"},{"key":"14159_CR5","doi-asserted-by":"publisher","unstructured":"Walter J, Haller S, Quinten C, et al. Healthcare-associated pneumonia in acute care hospitals in European Union\/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012. Eurosurveillance. 2018;23(32). https:\/\/doi.org\/10.2807\/1560-7917.es.2018.23.32.1700843.","DOI":"10.2807\/1560-7917.es.2018.23.32.1700843"},{"key":"14159_CR6","doi-asserted-by":"publisher","unstructured":"Paterson DL, Ko W c., Von Gottberg A et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum -lactamases. Clin Infect Dis. 2004;39(1):31\u201337. https:\/\/doi.org\/10.1086\/420816.","DOI":"10.1086\/420816"},{"key":"14159_CR7","doi-asserted-by":"publisher","unstructured":"Al-Zalabani A, AlThobyane OA, Alshehri AH, Alrehaili AO, Namankani MO, Aljafri OH. Prevalence of Klebsiella pneumoniae antibiotic resistance in medina, Saudi Arabia, 2014\u20132018. Cureus. 2020 Aug. https:\/\/doi.org\/10.7759\/cureus.9714.","DOI":"10.7759\/cureus.9714"},{"issue":"3","key":"14159_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/femsre\/fux013","volume":"41","author":"S -Navon-Venezia","year":"2017","unstructured":"Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev. 2017;41(3):252\u201375. https:\/\/doi.org\/10.1093\/femsre\/fux013.","journal-title":"FEMS Microbiol Rev"},{"key":"14159_CR9","unstructured":"Ashurst JV, Dawson A. Klebsiella. pneumonia. StatPearls - NCBI Bookshelf. . Published July 20, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519004\/."},{"key":"14159_CR10","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI supplement M100. Wayne, PA: CLSI; 2023."},{"key":"14159_CR11","unstructured":"Lower Respiratory tract Infections Management Protocol. Ministry of Health. https:\/\/www.moh.gov.sa\/Ministry\/MediaCenter\/Publications\/Documents\/Lower-Respiratory-Tract-Infections-Management-Protocol.pdf."},{"issue":"1","key":"14159_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.15537\/smj.2018.1.21094","volume":"39","author":"IA -Al-Zahrani","year":"2018","unstructured":"Al-Zahrani IA, Alasiri BA. The emergence of carbapenem-resistant Klebsiella pneumoniae isolates producing OXA-48 and NDM in the Southern (Asir) province, Saudi Arabia. Saudi Med J. 2018;39(1):23\u201330. https:\/\/doi.org\/10.15537\/smj.2018.1.21094.","journal-title":"Saudi Med J"},{"key":"14159_CR13","unstructured":"Alnemri AR, Almaghrabi RH, Alonazi N, Alfrayh AR. Misuse of antibiotic: a systematic review of Saudi published studies. Curr Pediatr Res. 2016; 20(1&2):169\u2013173. https:\/\/www.alliedacademies.org\/articles\/misuse-of-antibiotic-a-systemic-review-of-saudi-published-studies.html"},{"issue":"3","key":"14159_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cmi.2022.12.006","volume":"29","author":"BJ -Langford","year":"2023","unstructured":"Langford BJ, Soucy JR, Leung V, et al. Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis. Clin Microbiol Infect. 2023;29(3):302\u20139. https:\/\/doi.org\/10.1016\/j.cmi.2022.12.006.","journal-title":"Clin Microbiol Infect"},{"key":"14159_CR15","unstructured":"Kingdom of Saudi Arabia. Health Sector Transformation Program. Vision 2030. 2022. Available at: https:\/\/www.vision2030.gov.sa\/en\/explore\/programs\/health-sector-transformation-program."},{"key":"14159_CR16","unstructured":"Ministry of Health, Kingdom of Saudi Arabia. National Action Plan on Combating Antimicrobial Resistance. Riyadh: Ministry of Health. 2017 (2nd edition 2022\u20132025). World Health Organization National Action Plan Library."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14159-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14159-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14159-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:55:07Z","timestamp":1789120507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-14159-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14159"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14159-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Qassim Regional Research Ethics Committee, General Directorate of Health Affairs, Ministry of Health, Saudi Arabia (Approval No. 607\/45\/3771, dated October 4, 2023). This manuscript is part of a larger approved research project entitled \u201cEvaluating the\n                      Klebsiella pneumoniae\n                      Antibiotic Activity in Buraydah, Saudi Arabia.\u201d The current manuscript title was modified for clarity and publication purposes, but the study was conducted entirely under the same approved protocol. The study was conducted in accordance with the Declaration of Helsinki. Due to the retrospective nature of the study and the use of anonymized patient records, the requirement for informed consent was waived by the ethics committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1647"}}